To examine whether honokiol inhibits NSCLC cell migration by targeting the endogenous expression of COX-2, we determined the levels of COX-2 in lysates of cells treated with and without honokiol using western blot analysis. This evidence concerns the gene PTGS2 and non-small cell lung carcinoma.